A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease

• Published in: Journal of artificial organs Vol. 19; no. 1; pp. 100 - 103
• Main Authors: Yatabe, Tomoaki, Nakamura, Ryu, Kitagawa, Hiroyuki, Munekage, Masaya, Hanazaki, Kazuhiro
• Format: Journal Article
• Language: English
• Published: Tokyo Springer Japan 01.03.2016; Springer Nature B.V
• Subjects: Biomedical Engineering and Bioengineering; Blood Glucose - analysis; Cardiac Surgery; Case Report; Female; Glucose - therapeutic use; Glycogen Storage Disease - blood; Glycogen Storage Disease - surgery; Hepatectomy; Humans; Hypoglycemia - blood; Hypoglycemia - drug therapy; Hypoglycemic Agents - therapeutic use; Insulin - therapeutic use; Japan; Medicine; Medicine & Public Health; Middle Aged; Nephrology; Pancreas, Artificial; Artificial pancreas; Glycogen storage disease; Perioperative management
• ISSN: 1434-7229; 1619-0904
• DOI: 10.1007/s10047-015-0855-8

A 57-year-old woman was diagnosed with type I glycogen storage disease in her twenties. She had undergone hepatectomy under general anesthesia with epidural anesthesia. Fifty minutes after the induction of anesthesia, a 20-gauge venous catheter was inserted in the patient’s right hand, and an artificial pancreas (STG-55, Nikkiso Co., Tokyo, Japan) was connected for continuous glucose monitoring and automatic glucose control. Insulin was infused when the blood glucose level reached 120 mg/dL or higher, and glucose was infused when the level fell to 100 mg/dL or lower. After the Pringle maneuver, the blood glucose level increased, and insulin was administered automatically via an artificial pancreas. Hypoglycemia did not occur during the operation. After total parenteral nutrition was started in the intensive care unit (ICU), the blood glucose level increased, and the artificial pancreas controlled the blood glucose level through automatic insulin administration. Thirty-four hours after admission to the ICU, the artificial pancreas was removed because the blood sampling failed. After the removal of the artificial pancreas, blood glucose level was measured every 2 h until extubation. During the ICU stay, hypoglycemia never occurred, with the average blood glucose level being 144 mg/dL. In conclusion, the use of an artificial pancreas for perioperative blood glucose management in a patient with glycogen storage disease had the beneficial effect of enabling the management of blood glucose levels without hypoglycemia.